Home » Prices » NASDAQ:CYTK

Cytokinetics, Incorporated stock price

Today's NASDAQ:CYTK chart, history & news

Price:
17.15 USD
Change:
+0.56 (3.38%)
Key Stats
Price open 16.66
Previous close 16.59
Market cap 1.21B
Volume 455.37K
Day high 17.23
Day low 16.6
Year high 28.96
Year low 8.75
Year to date change 65.94%
P/E Ratio -9.27
Company Profile
Fundamentals
Insider Information
News

About Cytokinetics, Incorporated

Cytokinetics, Inc. operates as a biopharmaceutical company, which focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases. It conducts a Phase 2 clinical trials program for tirasemtiv, including a Phase 2b clinical trial in patients with ALS, known as BENEFIT-ALS (Blinded Evaluation of Neuromuscular Effects and Functional Improvement with Tirasemtiv in ALS). The company was founded on August 5, 1997 and is headquartered in South San Francisco, CA.

Company information

Company name
Cytokinetics Inc
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
156
CEO
Robert I. Blum
Address
280 East Grand Avenue, South San Francisco, CA, 94080
Country
United States
Contact information
1.650.624.3000
Website
http://www.cytokinetics.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.